What is it about?

The coronavirus SARS-CoV-2 can be found in saliva, and the lining of the mouth carries the receptors the virus uses to enter cells. We compared the bacteria living in the mouth (oral microbiota) and the inflammatory molecules (cytokines) in saliva and blood of 26 patients with severe COVID-19, not yet treated, and 15 healthy controls. COVID-19 patients had fewer bacterial species and a clearly different community: Prevotella salivae and Veillonella infantium were typical of patients, whereas Neisseria perflava and Rothia mucilaginosa dominated in controls. These two groups of bacteria formed opposite clusters in the bacterial network. Pro-inflammatory cytokines related to COVID-19 were found in both saliva and blood, together with a group of bacteria that seemed able to counteract them. We also developed an index, CytoCOV, that predicted COVID-19 status with high accuracy in this pilot study.

Featured Image

Why is it important?

The mouth is both an entry gate and a reservoir for SARS-CoV-2. This pilot study shows that severe COVID-19 is associated with a distinctive oral microbiota linked to local and systemic inflammation, suggesting that oral bacterial communities could serve as biomarkers or even be targeted to reduce local inflammation. Larger studies are needed to confirm these findings.

Perspectives

During the first pandemic waves, our group in Trieste tried to look at COVID-19 from every possible angle. Exploring the oral microbiota with our molecular microbiology colleagues was an original way to study the interplay between the virus, bacteria and inflammation. The microbiota keeps surprising us in every field of infectious diseases.

Professor Stefano Di Bella
Universita degli Studi di Trieste

Read the Original

This page is a summary of: Profiling of Oral Microbiota and Cytokines in COVID-19 Patients, Frontiers in Microbiology, July 2021, Frontiers,
DOI: 10.3389/fmicb.2021.671813.
You can read the full text:

Read

Contributors

The following have contributed to this page